Results
22
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
22 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GXI | €102.60 | 1.3% | -11.4% | €3.5b | €131.72 | PE30.7x | E22.3% | 1.2% | Pharmaceuticals & Biotech | ||
MBB | €100.60 | -1.9% | 23.9% | €575.1m | €124.67 | PE23.8x | E27.2% | 1.0% | Capital Goods | ||
HNL | €14.80 | -7.2% | -28.2% | €89.7m | €22.75 | PB1x | E119.1% | n/a | Capital Goods | ||
MTX | €265.50 | -2.1% | 23.8% | €14.3b | €267.14 | PS2.5x | E35.1% | 0.8% | Capital Goods | ||
VBK | €16.37 | -5.8% | -62.5% | €1.0b | €30.68 | PE54.2x | E66.9% | 1.2% | Energy | ||
TTR1 | €17.20 | 1.5% | -13.1% | €118.8m | €22.00 | PE15.7x | E26.1% | 3.6% | Capital Goods | ||
SCE | €4.12 | -8.4% | -45.6% | €15.5m | €8.00 | PB0.8x | E100.5% | 0% | Tech | ||
E4C | €12.55 | -4.2% | -26.6% | €44.2m | €38.70 | PE30.4x | E49.6% | 3.7% | Telecom | ||
ELB | €2.26 | 1.8% | -25.7% | €12.8m | €8.00 | PB1.8x | E120.2% | n/a | Consumer Durables | ||
LPK | €8.17 | -1.8% | 11.6% | €200.0m | €11.75 | PE84.9x | E68.8% | n/a | Tech | ||
SAP | €191.44 | -3.8% | 47.0% | €223.3b | €209.52 | PE87.2x | E37.9% | 1.1% | Software | ||
BSL | €9.67 | -1.8% | -25.7% | €297.3m | €14.80 | PS1.7x | E99.2% | 0% | Tech | ||
IXX | €38.10 | 2.1% | 32.3% | €376.3m | €52.25 | PE20.2x | E21.6% | 1.8% | Software | ||
EQS | €39.40 | 0% | 90.3% | €394.9m | €37.50 | PS5.5x | E115.5% | 0% | Software | ||
SJJ | €13.00 | -2.3% | 53.7% | €136.5m | €20.50 | PS1.4x | E114.4% | 0% | Software | ||
ADS | €222.00 | -4.1% | 26.1% | €39.6b | €237.77 | PE202.2x | E41.8% | 0.3% | Consumer Durables | ||
PBB | €5.65 | 12.3% | -21.3% | €759.1m | €6.38 | PE21.1x | E40.2% | n/a | Diversified Financials | ||
S9I | €48.50 | 0.8% | 53.5% | €315.3m | €45.75 | PE26.2x | E23.2% | 2.1% | Tech | ||
FYB | €51.80 | -1.7% | -12.9% | €914.6m | €84.78 | PE14.3x | E30.5% | n/a | Pharmaceuticals & Biotech | ||
C3RY | €1.97 | -10.8% | -61.7% | €45.7m | €3.88 | PB0.4x | E135.5% | n/a | Tech | ||
SUSE | €10.89 | -0.2% | -41.9% | €1.9b | €14.44 | PS3x | E117.7% | 28.4% | Software | ||
CEK | €5.25 | 6.7% | 43.4% | €41.5m | €8.11 | PS1.6x | E48.7% | 2.9% | Tech |